• SENSEX 76,917.85
    1,225.07 (+1.62%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,814.50 1,878.00(%)
  • Jio Platforms
    1,440.80 1,490.00(%)
  • Bharti Airtel
    2,080.70 2,174.70(%)
  • Reliance Industries
    1,307.00 1,611.20(%)
  • BLS Polymers
    285.25 285.25(%)
  • Solar Industries
    20,860.00 22,630.05(%)
  • Multi Comm. Exc.
    3,537.00 3,537.00(%)
  • Aegis Logistics
    1,253.90 1,528.00(%)
  • SBI
    961.35 933.85(%)
  • HDFC Bank
    725.70 1,017.90(%)
  • Oil India
    451.30 395.75(%)
  • Garden Reach Sh.
    2,235.00 3,338.90(%)
  • Divi's Lab.
    10,035.00 10,035.00(%)
  • M & M Fin. Serv.
    267.15 415.00(%)
  • Sagility
    41.98 35.82(%)
  • SFC Enviro.
    424.85 424.85(%)
  • Mankind Pharma
    2,523.70 2,640.30(%)
  • M & M
    2,910.95 3,840.00(%)
  • Kanohar Elect.
    1,165.90 1,210.00(%)
  • Laurus Labs
    2,252.50 913.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Advanced Enzyme Technologies Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 19816.0
  • ISIN : INE837H01020
274.25 -7 (-2.56%)
  • As on 03 Nov 2026 (EOD)

  • Today’s Low

    269.05

  • Today’s High

    284.10

  • Open

    278.80

  • Perv Close

    281.45

  • 52W Low

    246.80

  • 52W High

    419.00

Key Indicators

  • P/E(TTM)

    29.93

  • Mar.Cap (₹Cr.)

    3,070.95

  • Div & Yield %

    1.96

  • Book Value(₹)

    63.29

  • Debt-Equity Ratio

    -2.56

  • AGM Date

    03-Nov-2026

  • EPS

    9.13

  • P/E Ratio

    29.93

Financials Ratios

  • Debt-Equity Ratio

    0.03

  • Mar.Cap (₹Cr.)

    3,070.95

  • RONW (%)

    10.70

  • ROCE (%)

    14.53

Score Board

  • Equity (₹ in Cr.)

    22.40

  • BV (₹)

    63.30

  • Sales( ₹ in Cr.)

    452.77

  • NP (in Cr.)

    135.03

  • NP Var(%)

    32.0

  • Div%

    268.0

  • CPS (₹)

    13.10

  • EPS (₹)

    12.10

  • Traded Value (₹ in Lakhs)

    3,155.49

  • 52 Week High

    419.00

  • 52 Week Low

    246.80

  • Price BSE

    282.0

  • Price NSE

    281.00

  • Market Capital( in Cr.)

    3,155.49

  • P/C Ratio

    21.50

  • P/E Ratio

    23.40

  • Price Vs.BV

    12.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 452.77 351.41 365.47 311.53 272.80 283.47
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 452.77 351.41 365.47 311.53 272.80 283.47
Other Income 63.39 61.49 58.81 9.81 9.08 6.82
Stock Adjustments 3.08 6.47 7.83 -1.48 13.52 -1.27
Total Income 519.24 419.37 432.11 319.86 295.40 289.02
EXPENDITURE :            
Raw Materials 187.72 148.80 139.56 121.43 112.72 95.03
Power and Fuel Cost 23.69 18.52 22.73 19.58 16.19 11.53
Employee Cost 64.73 56.04 49.39 41.42 39.32 34.23
Other Manufacturing Expenses 20.05 19.74 18.57 14.52 13.53 9.25
Selling and Administration Expenses 44.34 38.17 33.64 32.37 28.66 28.58
Miscellaneous Expenses 8.46 5.67 22.95 5.64 3.08 2.81
Employee Benefit Expenses 64.73 56.04 49.39 41.42 39.32 34.23
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 348.98 286.93 286.83 234.97 213.49 181.44
Operating Profit 170.26 132.44 145.28 84.89 81.90 107.58
Interest 0.50 0.51 0.39 0.33 0.27 0.22
Gross Profit 169.76 131.93 144.89 84.56 81.63 107.36
Depreciation 12.08 11.41 10.90 10.28 9.56 8.93
Profit Before Tax 157.68 120.52 133.99 74.28 72.07 98.43
Current Tax 27.07 16.89 26.95 18.25 18.02 24.84
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.20 1.22 -1.08 0.50 -0.46 2.57
Reported Net Profit 131.81 102.42 108.12 55.53 54.51 71.01
Extraordinary Items -3.22 0.07 -15.13 -0.59 0.89 0.51
Adjusted Net Profit 135.03 102.35 123.25 56.12 53.62 70.50
Adjustment below Net Profit 0.84 -0.34 -0.10 0.49 0.02 -0.03
P & L Balance brought forward 514.66 469.61 417.50 372.66 328.19 263.91
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 58.18 57.03 55.91 11.18 10.06 6.70
P & L Balance carried down 589.13 514.66 469.61 417.50 372.66 328.19
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 267.50 260.00 255.00 50.00 50.00 45.00
Dividend Per Share(Rs) 5.35 5.20 5.10 1.00 1.00 0.90
Earnings Per Share-Unit Curr 11.78 9.15 9.67 4.97 4.88 6.36
Earnings Per Share(Adj)-Unit Curr 11.78 9.15 9.67 4.97 4.88 6.36
Book Value 63.38 56.25 51.91 46.98 42.97 38.97
Book Value(Adj)-Unit Curr 63.38 56.25 51.91 46.98 42.97 38.97

Shareholding Pattern

  • Promoter Group

    43.56%

  • Public Share Holding

    56.44%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 38,738,885 38,738,885.00 38,738,885 38,738,885
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 46,238,885 41.60 46,238,885 6
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 2,180,600 1.96 2,180,600 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 2,180,600 1.96 2,180,600 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 13,509,522 12.15 13,509,522 1
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 16,109,390 14.49 16,109,390 69
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,310,288 1.18 1,310,288 8
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 789,707 0.71 789,707 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 31,718,907 28.54 31,718,907 84
2] Non Institution
Bodies Corporate 2,341,659 2.11 2,341,659 311
Clearing Members 34,088 0.03 34,088 22
Directors of their Relatives 1,903,500 1.71 1,903,500 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3,716,610 3.34 3,716,610 1,754
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 698,806 0.63 698,806 1,606
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,706,171 1.54 1,706,171 6
Individuals holding nominal share capital up to Rs. 1 lakh 19,028,574 17.12 18,839,574 63,614
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 552,700 0.50 552,700 2
Others 740,524 0.67 740,524 15
Sub Total 31,012,730 27.90 30,823,730 67,368
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 111,151,122 100.00 110,962,122 67,468

Company Background

Advanced Enzyme Technologies LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Advanced Enzyme Technologies Ltd
  • BSE Code : 19816.0
  • ISIN : INE837H01020

  • Incorporation Year

    1989

  • Registered Office

    Sun Magnetica 5th Floor
    Nr LIC Serivce Road Louiswadi, Thane,
    Maharashtra-400604

  • Telephone

    91-22-41703200

  • FAX

    91-22-25835159

  • Chairman

    VASANT RATHI

  • Managing Director

  • Company Secretary

  • Auditor

    MSKA & Associates LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Advanced Enzyme Technologies Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Advanced Enzyme 273.30 516.15 452.77 30.74 23.45
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77